To reconstitute a 10mg KPV research vial, laboratories typically add 1.0 mL to 2.0 mL of bacteriostatic water. Adding 1.0 mL yields a final concentration of 10 mg/mL (10 µg/µL), whereas 2.0 mL provides 5 mg/mL (5 µg/µL). The exact volume depends on required pipetting precision for in vitro or preclinical animal assays.
To reconstitute a 10mg KPV research vial, laboratories typically add 1.0 mL to 2.0 mL of bacteriostatic water. Adding 1.0 mL yields a final concentration of 10 mg/mL (10 µg/µL), whereas 2.0 mL provides 5 mg/mL (5 µg/µL). The exact volume depends on required pipetting precision for in vitro or preclinical animal assays.
Determining how much bac water for KPV 10mg reconstituted vials requires matching liquid diluent volumes to the target experimental concentration. For high-concentration assay stock solution preparation, adding 1.0 mL of bacteriostatic water into a 10 mg vial of KPV 10mg produces a 10 mg/mL solution, where each 0.1 mL volume contains 1.0 mg of target peptide.
Alternatively, if higher volumetric precision is necessary for low-dose micro-pipetting in cell culture setups, adding 2.0 mL of diluent yields 5.0 mg/mL (5.0 µg/µL). For broader analytical screening, adding 5.0 mL of diluent results in a 2.0 mg/mL concentration. Researchers should reference their specific assay parameters prior to reconstituting lyophilized peptide cakes.
KPV is a tripeptide consisting of the amino acid sequence Lysine-Proline-Valine (Lys-Pro-Val). Derived as a C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH), KPV retains significant anti-inflammatory functionality without demonstrating melanotrophic agonist properties at melanocortin receptors.
In preclinical research, KPV interacts directly with intracellular inflammatory cascades. In vitro assays and murine models indicate that KPV acts primarily via the peptide transporter PepT1, which is heavily expressed in intestinal epithelial cells. Upon cellular internalization, KPV inhibits nuclear factor kappa B (NF-κB) nuclear translocation, subsequently suppressing down-stream inflammatory cytokines including TNF-α, IL-6, and IL-8. Institutional researchers evaluate KPV within mucosal barrier integrity models and inflammatory bowel disease (IBD) research framework.
Calculating dilution ratios for a 10mg KPV vial follows standard laboratory concentration equations: Concentration (C) = Mass (M) / Volume (V). Because KPV exhibits rapid aqueous solubility, diluent volumes can be varied without inducing peptide precipitation or cloudiness.
The following volumetric configurations outline common concentration outputs for a 10 mg lyophilized KPV vial:
• 1.0 mL Bacteriostatic Water = 10.0 mg/mL (10.0 µg per microliter) • 2.0 mL Bacteriostatic Water = 5.0 mg/mL (5.0 µg per microliter) • 2.5 mL Bacteriostatic Water = 4.0 mg/mL (4.0 µg per microliter) • 5.0 mL Bacteriostatic Water = 2.0 mg/mL (2.0 µg per microliter)
Review our comprehensive peptide reconstitution guide for additional mathematical formulas and step-by-step laboratory dilution workflows.
For multi-use laboratory sampling over extended trial periods, bacteriostatic water containing 0.9% (9 mg/mL) benzyl alcohol is the preferred diluent. Benzyl alcohol acts as a bacteriostatic preservative, inhibiting microbial cell replication during repeated vial entry across 28 days of refrigerated storage at 2°C to 8°C.
Sterile Water for Injection (SWFI) lacks antimicrobial agents. While suitable for single-assay applications where immediate total sample consumption occurs, unpreserved solutions present elevated contamination risks if stored for multi-day protocols. For long-term stability in institutional setting assays, bacteriostatic water remains the standard choice for anti-inflammatory research peptides.
When designing gastrointestinal barrier assays or anti-inflammatory comparative models, researchers often evaluate KPV alongside related signaling peptides. While KPV operates via PepT1 cellular transport and NF-κB transcription pathways, BPC-157 acts through VEGFR2 activation and focal adhesion kinase pathways to accelerate tissue repair.
Additionally, research teams investigate Larazotide for its tight-junction regulating properties via zonula occludens inhibition, while LL-37 functions as an antimicrobial peptide modulating innate immune cell migration. Combining these compounds in comparative in vitro assays allows investigators to isolate distinct mechanisms of mucosal protection and barrier restoration.
Rigorous quantitative analysis is required to ensure reproducibility in peptide research. Every lot of KPV manufactured for PX1 Research undergoes stringent verification to guarantee molecular integrity and purity.
Our quality control sequence includes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to verify chemical purity (>99%), Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm exact molecular weight (383.48 g/mol), and Chromogenic LAL testing (USP <85>) to confirm endotoxin levels below 0.005 EU/mg. Certificate of Analysis (COA) documents per lot are fully accessible across our all research peptides catalog.
Proper reconstitution techniques prevent physical degradation of the tripeptide chain. When adding bacteriostatic water to a KPV 10mg vial, direct the stream down the interior glass wall rather than spraying directly onto the lyophilized cake. Allow the cake to dissolve naturally or assist dissolution using gentle swiveling; avoid vigorous vortexing, which can introduce shear stress.
Prior to reconstitution, store dry lyophilized KPV at -20°C in a desiccated environment. Reconstituted KPV solutions in bacteriostatic water remain stable at 2°C to 8°C for up to 28 days. For extended storage of liquid stock solutions beyond 30 days, freeze reconstituted aliquots at -80°C to avoid repeated freeze-thaw degradation cycles.
Preclinical studies indicate that KPV exerts targeted anti-inflammatory effects in epithelial barrier assays. In vitro research utilizing Caco-2 cell monolayers demonstrates that KPV exposure reduces dextran sulfate sodium (DSS)-induced epithelial permeability and preserves tight junction proteins like ZO-1 and Occludin.
In animal models of colitis, orally administered or intraperitoneally delivered KPV nanoparticles significantly diminished histological inflammation scores and reduced colonic myeloperoxidase (MPO) activity. Researchers exploring cytokine modulation pathways can consult further literature in the PX1 research library.
PX1 Research supplies USA-manufactured research peptides designed strictly for laboratory evaluation. Each batch of KPV 10mg is synthesized under GMP-compliant processes, ensuring lot-to-lot consistency and verifiable purity standards.
Institutional labs and high-throughput facility buyers can access bulk volume quotes and dedicated account management through our PX1 wholesale portal. All orders ship directly from CA and AZ fulfillment hubs with same-day dispatch for orders finalized Monday through Friday prior to cutoff times.
how much bac water for kpv 10mg
For a 10mg KPV vial, adding 1.0 mL of bacteriostatic water results in a 10 mg/mL concentration (10 µg/µL). Adding 2.0 mL yields a 5 mg/mL concentration (5 µg/µL), while 5.0 mL creates a 2 mg/mL concentration (2 µg/µL).
kpv 10 mg how much bac water
The volume of bac water used for KPV 10 mg depends on desired lab concentration: 1 mL diluent produces 10 mg/mL, 2 mL produces 5 mg/mL, and 2.5 mL yields 4 mg/mL for micro-pipetting.
What is the molecular weight and sequence of KPV?
KPV is a tripeptide with the sequence Lysine-Proline-Valine (Lys-Pro-Val) and a molecular weight of 383.48 g/mol.
Why is bacteriostatic water preferred over sterile water for KPV?
Bacteriostatic water contains 0.9% benzyl alcohol, which prevents bacterial growth during repeated multi-dose sampling across 28 days under refrigeration.
What is the shelf life of reconstituted KPV in bacteriostatic water?
Reconstituted KPV stored in bacteriostatic water remains stable at 2°C to 8°C for up to 28 days. Aliquots stored at -80°C remain viable for longer analytical windows.
How does KPV compare to BPC-157 in preclinical models?
While KPV operates primarily via PepT1 cellular transport and NF-κB inhibition, BPC-157 acts via angiogenesis acceleration and VEGFR2 activation.
Does PX1 Research provide lot-specific COAs for KPV 10mg?
Yes. Every lot of PX1 KPV 10mg is tested via RP-HPLC, Mass Spectrometry, and Endotoxin assay, with COAs available on request and linked on product pages.
What is the endotoxin threshold for PX1 KPV research peptides?
PX1 research peptides undergo chromogenic LAL testing (USP <85>) and are verified to contain less than 0.005 EU/mg of bacterial endotoxins.
Can KPV be repeatedly frozen and thawed after reconstitution?
Repeated freeze-thaw cycles degrade peptide structural integrity. Laboratories should aliquot reconstituted KPV into single-use volumes prior to freezing.
How can institutional laboratories purchase bulk quantities of KPV 10mg?
Institutional account managers and head researchers can submit bulk request quotes directly through the PX1 Research wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.